Top news of the week: 19.05.2020.
Biotechnology, Vaccination, Antibody, Drug, Microbiology, Effectiveness
Healthcare
Lava Therapeutics and Janssen Biotech to Collaborate on Cancer Treatment Research https://t.co/ReymjZ4awG https://t.co/I3fczCITwH
OpenLava Therapeutics and Janssen Biotech to Collaborate on Cancer Treatment Research
The goal is to discover and develop novel bispecific antibodies to gamma-delta T cells for the treatment of cancer.
RT @SWLifeSciences: Acceleration of COVID-19 Vaccine Programs Could Benefit U.S. Biotech: https://t.co/MCAwq40Te9
The development timeline for Inovio Pharmaceuticals' coronavirus vaccine candidate is discussed in an H.C. Wainwright & Co. report.
$INO https://t.co/1sHVB42s8A
OpenAcceleration of COVID-19 Vaccine Programs Could Benefit U.S. Biotech Research Report
The development timeline for Inovio Pharmaceuticals' coronavirus vaccine candidate is discussed in an H.C. Wainwright & Co. report.
RT @jmaxlevin: It was a great honor to initiate and participate in the search that ultimately led us to @DrMichelleBIO. Her experience, coupled with her focus on patients and driving innovation, is exactly what we need to lead @IAMBiotech now and into the future. https://t.co/LCM320othJ
OpenBIO Appoints a Physician-Scientist as New President and CEO
Immunologist Michelle McMurry-Heath is Selected for Her Global Leadership and Commitment to Innovation and Patients Former FDA Official Will Succeed Industry Leader Jim Greenwood on June ...
RT @beisgovuk: Discovering a vaccine is the only way to defeat #coronavirus once and for all.
The new chair of our Vaccine Taskforce, Kate Bingham, will play a critical role in coordinating work already underway to rapidly develop and mass produce vaccines: https://t.co/nZRzdvSc6z https://t.co/RIUMCteY22
OpenKate Bingham appointed chair of UK Vaccine Taskforce
Kate Bingham has been appointed chair of the UK’s Vaccine Taskforce
RT @kenkaitin: Interesting application of AI to guide off-label prescribing of prescriptions medicines. https://t.co/An8IL6FlI6 via @financialtimes @TuftsCSDD
OpenDrugmakers get hooked on data
Pharma groups hope troves of patient records hold key to faster cures and bigger profits
RT @meagfw: The 3 Best Biotech Stocks to Own in 2020: $MRNA, $TGTX, $CRSP | InvestorPlace https://t.co/ylFfksZLPG
OpenThe 3 Best Biotech Stocks to Own in 2020
By 2024, the biotech sector could rocket to $775 billion with plenty of long-term growth catalysts. And that's great news for biotech stocks.
Sorrento IDs Antibody Against COVID-19 That Appears 100% Effective https://t.co/pGnesFzo3p https://t.co/sMztlGqyNy
OpenSorrento IDs Antibody Against COVID-19 That Appears 100% Effective
The company announced that one of its antibodies, STI-1499, has shown 100% inhibition of SARS-CoV-2 in laboratory tests.
RT @CNBC: Moderna reported encouraging results from its early-stage coronavirus vaccine trial. @megtirrell breaks down the details, and explains what this means for the vaccine development timeline. https://t.co/oo52yVT4Kr https://t.co/0h44Jf2gBt
OpenModerna reports positive data on early-stage coronavirus vaccine trial, shares surge
Moderna said its early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all participants, sending its shares surging.